Global Allergy Treatment Market: Snapshot
The demand in the global allergy treatment market is projected to increment at a healthy CAGR of 5.5% during the forecast period of 2017 to 2025, gaining traction from a number of factors such as presence of vast unmet medical needs in various emerging economies, growing prevalence of asthma and allergic rhinitis along with high consumption of tobacco, various novel molecules in pipeline, and upsurge in allergies as a result of environmental pollution. While high cost of immunotherapy and increasing preference of complementary and alternative medicines (CAM) are still hindering the market from attaining its true potential, the vendors of this market will gain new opportunities from the advent of SPIRE, emergence of sublingual immunotherapy (SLIT), and identification of new allergen targets.
Inhaled Allergy Leading Allergy-Type Segment
Based on allergy type, the report segments the global allergy treatment market into inhaled allergy, food allergy, and drug allergy, and foresees a considerable chunk of demand coming for inhaled allergy segment throughout the forecast period. Also known as respiratory allergy, allergic rhinitis and asthma are some of the most common inhaled allergies that affect most of the population across the globe. As per the estimation of the World Allergy Organization (WAO), in 2015, nearly 500 million people were affected by allergic rhinitis. Increasing CO2 levels and changing climate as a result of environmental pollution are pushing inhaled allergy segment, currently required to cater to about a billion people across the world.
Treatment-wise, the global allergy treatment market is categorized into anti-allergy drugs and immunotherapy. While anti-allergy drugs currently serve the maximum demand, progress in the field of immunotherapy is expected to escalate its demand too during the forecast period. Based on distribution channel, retail pharmacies and drug stores segment served the maximum demand, and is expected to sustain its position throughout the forecast period, although online retail are also gaining popularity.
North America Continues to Serve Maximum Demand
Out of five regions analyzed by this report for their potential for allergy treatment market, viz. North America, Asia Pacific, Europe, Latin America, and The Middle East and Africa, North America accounted for the maximum demand in 2016, in terms of value. A number of pharmaceutical companies in this region are focused on the development of new and advanced allergy treatment, such as SLIT. Prevalence of various types of allergies in this region, robust healthcare infrastructure in developed countries such as the U.S. and Canada, government support for R&D activities, and flourishing life science market are some of the key factors driving the allergy treatment market in the region of North America. As per the estimation of the American Academy of Allergy Asthma and Immunology, nearly 27.2 million people in the country of the U.S. suffered from allergic rhinitis in 2015, whereas about 26 million people had asthma. This substantial demand is the expected to maintain North America are most lucrative region for the stockholders of the global allergy treatment market.
ALK-Abelló A/S, GlaxoSmithKline plc., and Stallergenes Greer are three prominent companies currently accounting for the maximum share in the global allergy treatment market, dominating via their impressive product portfolio and widespread geographical outreach. Some of the other prominent players operating in the global allergy treatment market are Meda Pharmaceuticals Inc., Allergy Therapeutics, Sunovion Pharmaceuticals Inc., Allergon AB, Allergan, HAL Allergy Group, and Teva Pharmaceutical.
Global Allergy Treatment Market: Overview
The allergy treatment market is the highly growing market in developed and developing countries due to the fast growing life science industry, rising focus on new treatment development for allergy specific drugs, and increasing prevalence of allergic diseases. The market overview section of the report comprises qualitative analysis of the overall allergy treatment market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five force analysis and market attractiveness analysis. In addition, market opportunity analysis for product for global as well as Asia Pacific has also been provided. The report also comprises prevalence of allergy by type, and by region.
Global Allergy Treatment Market: Segmentations
The global allergy treatment market has been segmented on the basis of allergy type, treatment, and distribution channel. The allergy type segment is further segmented as, food allergy, inhaled allergy, drug allergy, and other includes skin allergy, eye allergy etc. inhaled allergy segment accounted major share in 2016 of allergy treatment market and expected to register high CAGR over forecast period.
By treatment, the global allergy treatment market is segmented as, anti-allergy drugs and immunotherapy. The anti-allergy drugs accounted major share in 2016 of allergy treatment market. The segment is further segmented as, Antihistamines, Corticosteroids, Leukotriene Inhibitors, and Others).The immunotherapy segment is fast growing segment by treatment over the forecast period owing to rising demand for the allergy specific treatment. The segment is further segmented as subcutaneous immunotherapy (SCIT), and sublingual immunotherapy (SLIT). In market only few drugs are approved for SLIT immunotherapy, and many are in various stages of development.
On the basis of distribution channel, the global allergy treatment market is segmented as hospital pharmacies, retail pharmacies & drug stores, and online pharmacies. Retail pharmacies & drug stores segment accounted major share in 2016 by distribution channel in global allergy treatment market and expected to register high CAGR over forecast period. Rising over the counter purchasing of various anti-allergic drugs such as antihistamines, corticosteroids etc.to treat acute allergies are expected to drive the growth of segment over the forecast period. Moreover, rising boom of online purchasing of medicines is expected to drive the growth of online pharmacies segment over the forecast period.
The market for these allergy type, treatment and distribution channel has been extensively analyzed on the basis of factors such as usage pattern, sales revenue, and geographic presence of major market players and their product developments. The market size and forecast in terms of revenue (US$ million), for each of these segments, and the sub-segments have been provided for the period 2015 to 2025, considering 2016 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment for the forecast period 2017 to 2025. Geographically, the allergy treatment market has been classified into five segments namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The market size forecast for each region has been provided for the period 2015 to 2025, in terms of allergy type, treatment and distribution channel, along with the CAGR (%) for the forecast period 2017 to 2025.
Global Allergy Treatment Market: Competitive Landscape
The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global allergy treatment market, in terms of percentage share in 2016 has been provided. The report concludes with the profiles of major players in the global allergy treatment market such as ALK, Stallergenes Greer, Allergy Therapeutics, Meda Pharmaceuticals Inc., GlaxoSmithKline plc, Sunovion Pharmaceuticals Inc., Allergan, Allergon AB, HAL Allergy Group among others. The major market players are evaluated on various parameters such as company overview, financial overview, product portfolio, business strategies and recent developments.
The global Allergy treatment market is segmented as given below:
Allergy treatment Market, by Allergy Type
- Food Allergy
- Inhaled Allergy
- Drug Allergy
Allergy treatment Market, by Treatment
- Anti-allergy Drugs
- Leukotriene Inhibitors
- Subcutaneous Immunotherapy (SCIT)
- Sublingual Immunotherapy (SLIT)
Allergy treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies & Drug Stores
- Online Pharmacies
Global Allergy treatment Market, by Major Region
- North America
- Rest of Europe
- Asia Pacific
- Australia & New Zealand
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa